Amarin (AMRN) Reports Q3 2025 Earnings with Revenue Growth and Margin Decline
Amarin (AMRN) reported Q3 2025 earnings with total revenue of $1.281 billion, a 6% year-over-year increase. The company saw growth across multiple segments, including Vision Care and Contact Lens, but experienced a 130 basis point decline in adjusted gross margin due to product mix and the enVista recall.
Tickers: $AMRN
Topics: Company Report Earnings Financial Performance Revenue Growth